Session VII
Basic science III

Programme

• 12:30 – 12:40 8 Min. 2 Min.

  • Oral presentation
  • O53

  Unlocking the potential of the VISTA/Galectin-9 immune checkpoint axis in pancreatic cancer

  • Dr. Helge Meyer (Oldenburg / DE)

   Tumour microenvironment, epigenetics and stem cells
• 12:40 – 12:50 8 Min. 2 Min.

  • Oral presentation
  • O54

  KRAS & GNAS mutations in cfDNA and circulating epithelial cells in patients with intraductal papillary mucinous neoplasms – an observational pilot-study regarding the risk of progression to pancreatic cancer

  • Marie Tölle (Hamburg / DE)

   Cystic lesions of the pancreas
• 12:50 – 13:00 8 Min. 2 Min.

  • Oral presentation
  • O55

  Growth of immune cells in 3D ex vivo culture of pancreatic cancer tumor fragments

  • Maurice Sagorsky (Düsseldorf / DE)

   Pancreatic cancer
• 13:00 – 13:10 8 Min. 2 Min.

  • Oral presentation
  • O56

  Irf3 and Irf7 are crucial factors for controlling a tumor-promoting epigenetic program

  • Lisa Fahr (Munich / DE)

   Pancreatic cancer
• 13:10 – 13:20 8 Min. 2 Min.

  • Oral presentation
  • O57

  Expression of Lysine Demethylase 5a (Kdm5a) affects metabolic activity and aggressiveness of murine pancreatic cancer cells

  • Nicole Schreiner (Großhadern / DE)

   Tumour microenvironment, epigenetics and stem cells
• 13:20 – 13:30 8 Min. 2 Min.

  • Oral presentation
  • O58

  Patient-Supported surveillance registry for pancreatic cystic lesions: The rlectronic concept of the Magdeburg cyst document

  • Dr. Sara Al-Madhi (Magdeburg / DE)

   Cystic lesions of the pancreas
• 13:30 – 13:40 8 Min. 2 Min.

  • Oral presentation
  • O59

  Mechanisms of CUX1-induced tumor progression in neuroendocrine tumors of the pancreas

  • Maryam Khosravian (Halle / DE)

   Pancreatic cancer
• 13:40 – 13:50 8 Min. 2 Min.

  • Oral presentation
  • O60

  GARP producing B cells amplifies the development and progression of pancreatic ductal adenocarcinoma

  • Dr. Paul David (Erlangen / DE)

   Pancreatic cancer
• 13:50 – 14:00 8 Min. 2 Min.

  • Oral presentation
  • O61

  Molecular characterization of the cell-intrinsic mechanisms driving NFATc1:STAT3-mediated PDAC tumor heterogeneity

  • Rebecca Diya Samuel (Göttingen / DE)

   Pancreatic cancer